
AdventHealth Participating in Phase I Clinical Trial of Potential New Oral Immunotherapy Treatment for Mild to Moderate Ulcerative Colitis
AdventHealth Research Institute is the first in Central Florida to participate in the expansion phase of a clinical trial exploring a potential new oral immunotherapy treatment for mild to moderate...